Ovarian cancer
Results
Phase 2
This trial was for women whose had stopped working.
It was for women with one of the following cancers:
ovarian cancer
primary peritoneal cancer
fallopian tube cancer
These cancers are treated in a similar way. When we use the term ovarian cancer in this summary, we are referring to all 3.
The trial was open for women to join between 2017 and 2020. The team published the results in 2024.
Cancer Research UK supported this trial.
Recruitment start: 9 March 2017
Recruitment end: 10 January 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Shibani Nicum
AstraZeneca
Cancer Research UK
NIHR Clinical Research Network: Cancer
University of Oxford
This is Cancer Research UK trial number CRUKE/15/016.
Last reviewed: 20 December 2024
CRUK internal database number: 13387